Towa Pharmaceutical Co., Ltd. (4553.T)
JPY 2808.0
(2.3%)
JPY 2808.0
(2.3%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 227.93 Billion | 208.85 Billion | 165.61 Billion | 154.9 Billion | 110.38 Billion | 105.1 Billion |
| Cost of Revenue | 146.55 Billion | 136.14 Billion | 95.42 Billion | 89.44 Billion | 59.73 Billion | 56.7 Billion |
| Gross Profit | 81.38 Billion | 72.71 Billion | 70.18 Billion | 65.45 Billion | 50.64 Billion | 48.39 Billion |
| Operating Expenses | 63.73 Billion | 67.19 Billion | 50.98 Billion | 45.52 Billion | 34.5 Billion | 32.43 Billion |
| Selling, General and Administrative Expenses | 50.49 Billion | 51.93 Billion | 40.16 Billion | 34.88 Billion | 25.9 Billion | 24.2 Billion |
| Research and Development Expenses | 13.24 Billion | 15.26 Billion | 11.48 Billion | 10.64 Billion | 8.56 Billion | 7.91 Billion |
| Other Expenses | - | 907 Million | 724 Million | 527 Million | 468 Million | 572 Million |
| Cost and Expenses | 210.28 Billion | 203.34 Billion | 146.4 Billion | 134.97 Billion | 94.24 Billion | 89.13 Billion |
| Operating Income | 17.64 Billion | 5.51 Billion | 19.2 Billion | 19.92 Billion | 16.14 Billion | 15.96 Billion |
| Interest Expense | 947 Million | 635 Million | 230 Million | 190 Million | 131 Million | 146 Million |
| Income Tax Expense | 8.28 Billion | 2.4 Billion | 6.33 Billion | 4.77 Billion | 6.2 Billion | 5.41 Billion |
| Earnings before Tax | 24.45 Billion | 4.6 Billion | 22.24 Billion | 18.72 Billion | 20.7 Billion | 18.88 Billion |
| Net Income | 16.17 Billion | 2.2 Billion | 15.91 Billion | 13.95 Billion | 14.5 Billion | 13.47 Billion |
| Earnings Per Share Basic | 328.58 | 44.72 | 323.35 | 283.62 | 294.72 | 253.32 |
| Earnings Per Share Diluted | 328.58 | 43.72 | 316.19 | 271.93 | 272.61 | 253.32 |
| Weighted Average Shares Outstanding | 49.22 Million | 49.22 Million | 49.21 Million | 49.21 Million | 49.2 Million | 53.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.22 Million | 50.34 Million | 50.32 Million | 51.27 Million | 53.17 Million | 53.19 Million |
| Gross Margin | 0.36 | 0.35 | 0.42 | 0.42 | 0.46 | 0.46 |
| EBIT Margin | 0.16 | 0.13 | 0.19 | 0.20 | 0.23 | 0.25 |
| Profit Margin | 0.07 | 0.01 | 0.10 | 0.09 | 0.13 | 0.13 |
| EBITDA | 35.53 Billion | 24.92 Billion | 29.49 Billion | 30.35 Billion | 24.45 Billion | 24.62 Billion |
| Earnings Before Tax Margin | 0.08 | 0.03 | 0.12 | 0.13 | 0.15 | 0.15 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 62.56 Billion | 59.6 Billion | 227.93 Billion | 60.92 Billion | 52.84 Billion | 54.54 Billion |
| Cost of Revenue | 39.22 Billion | 38.63 Billion | 146.55 Billion | 38.76 Billion | 34.61 Billion | 34.53 Billion |
| Gross Profit | 23.34 Billion | 20.97 Billion | 81.38 Billion | 22.16 Billion | 18.23 Billion | 20 Billion |
| Operating Expenses | 17.67 Billion | 16.53 Billion | 63.73 Billion | 15.96 Billion | 15.32 Billion | 15.91 Billion |
| Selling, General and Administrative Expenses | 17.67 Billion | 16.53 Billion | - | 12.59 Billion | 12.06 Billion | 15.91 Billion |
| Research and Development Expenses | 330 Million | 3.32 Billion | - | 3.37 Billion | 3.25 Billion | 3.28 Billion |
| Other Expenses | 1 Million | 326 Million | 525 Million | 110 Million | -147 Million | 236 Million |
| Cost and Expenses | 56.89 Billion | 55.16 Billion | 210.28 Billion | 54.72 Billion | 49.94 Billion | 50.45 Billion |
| Operating Income | 5.67 Billion | 4.44 Billion | 17.64 Billion | 6.2 Billion | 2.9 Billion | 4.09 Billion |
| Interest Expense | 331 Million | 273 Million | 947 Million | 262 Million | 220 Million | 192 Million |
| Income Tax Expense | 3.08 Billion | 2.51 Billion | 8.28 Billion | 2.33 Billion | 1.04 Billion | 2.39 Billion |
| Earnings before Tax | 8.58 Billion | 7.16 Billion | 24.45 Billion | 6.89 Billion | 3.25 Billion | 7.14 Billion |
| Net Income | 5.49 Billion | 4.65 Billion | 16.17 Billion | 4.56 Billion | 2.2 Billion | 4.75 Billion |
| Earnings Per Share Basic | 111.64 | 94.58 | - | 92.75 | 44.76 | 96.50 |
| Earnings Per Share Diluted | 111.64 | 94.58 | - | 92.75 | 44.76 | 96.50 |
| Weighted Average Shares Outstanding | 49.22 Million | 49.21 Million | 49.22 Million | 49.21 Million | 49.21 Million | 49.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.22 Million | 49.22 Million | 49.22 Million | 49.21 Million | 49.21 Million | 49.22 Million |
| Gross Margin | 0.37 | 0.35 | 0.36 | 0.36 | 0.34 | 0.37 |
| EBIT Margin | 0.17 | 0.15 | - | 0.11 | 0.06 | 0.08 |
| Profit Margin | 0.09 | 0.08 | 0.07 | 0.07 | 0.04 | 0.09 |
| EBITDA | 10.4 Billion | 9.11 Billion | - | 6.66 Billion | 3.11 Billion | 4.44 Billion |
| Earnings Before Tax Margin | 0.09 | 0.07 | 0.08 | 0.10 | 0.06 | 0.08 |
IB
BTGGF
ABBOTINDIA
DICIND
CNTRF
SRS